HR. 796In Committee
Second Chance for Moms Act
Requires mifepristone labeling to include specified information about progesterone and creates a related telephone hotline
Plain-English overview
What this bill does
Requires mifepristone labeling to include specified information about progesterone and creates a related telephone hotline
Key points
- Establish progesterone telephone hotline
- Require mifepristone labeling information
Current status
Where it stands
Status
In Committee
Latest action
2025-01-28 — Referred to the House Committee on Energy and Commerce.
Related context
Topics and policy areas
undefinedAbortionConsumer affairsHealthPrescription drugsSex and reproductive healthTelephone and wireless communicationWomen's health